Boehringer Ingelheim Resources and More...
Cymbalta® Approved in Europe for Depression
Cymbalta®/Xeristar® has been granted marketing authorization by the European Commission for the treatment of major depressive episodes, Eli Lilly and Company and Boehringer Ingelheim announced.......(Continue Reading)
Mobic
The latest info on Mobic....(Continue Reading)
Tipranavir gains FDA approval
The new protease inhibitor Tipranavir has gained FDA aproval....(Continue Reading)
The HIV Pipeline
Science continues to work on new ways to fight HIV and AIDS. Here is the latest news about new HIV drugs in development. What's in the HIV pipeline....(Continue Reading)
Drug Manufacturers
Information from the people who manufacture HIV medications....(Continue Reading)
In the Pipeline
What new hiv/aids drugs are heading down the pipeline to you?...(Continue Reading)
Duloxetine hydrochloride - Cymbalta - Xeristar - Information and Resources
Information and resources about the drug duloxetine hydrochloride - Cymbalta - Xeristar - a medication sometimes used to treat panic and anxiety disorders....(Continue Reading)
northwest technology center | national geographic traveler | new technology advances |
Recommended Boehringer Ingelheim Site:
Boehringer Ingelheim Corporate Website: Human Pharmaceuticals and …
Main site of Boehringer Ingelheim (Germany) that ranks among the top 20 pharmaceutical companies in the world. Features global activities, company history …
universal technology institute | high tech design | gsu edu |
earthlink tech support | zzr 1200 | advanced automotive technology | |